Patient Services, Inc. (PSI) is pleased to support the Patients’ Access to Treatments Act (PATA). This important bipartisan legislation introduced in the House of
Representatives this week by Reps. David B. McKinley (R-WV) and Lois Capps
(D-CA), will limit cost-sharing requirements for medications placed in a
specialty tier and make innovative and necessary medications more accessible by
reducing excessive out-of-pocket expenses.
This legislation is critical because patient’s with rare, chronic
conditions, like those that PSI serves, are increasingly facing out-of-pocket
expenses that are so unaffordable they sometimes forgo taking their medication
all together causing their condition to worsen and increase costs to the
medical system. PATA will ensure that our patients have affordable access to
their medications and we can continue to assist them as needed.
An alarming trend in today’s health insurance market is the practice of
moving more expensive drugs onto specialty tiers that utilize high patient
cost-sharing methods. The patient costs for drugs in specialty tiers can reach
into the thousands of dollars a month, placing medically-necessary treatments
out of reach of average insured Americans. For many patients, this leads to
failure to adhere to a treatment plan, which can lead to worsening disease, increased
rates of disability, and rising health care costs.
Services, Inc. (PSI) has helped patients with rare and expensive chronic
conditions afford their health insurance premiums and co-payments for over 25
years,” said Dana Kuhn, President and Founder, Patient Services, Inc. “Unfortunately, today we are extremely
concerned that access to needed, and often life-saving, treatments is becoming
more challenging for our patients because of rapidly increasing out-of-pocket
costs. By providing our patients with manageable cost-sharing, the Patients’
Access to Treatment Act (PATA) will ensure access for our patients.”
PSI is one of 32 members of the Coalition for Accessible Treatments, which
encourages patients and physicians to ask lawmakers to support and co-sponsor the Patients’ Access to Treatments Act of 2015.